血管生成
三七
基质凝胶
SMAD公司
阿拉伯半乳聚糖
化学
信号转导
癌症研究
血管生成抑制剂
新生血管
细胞生物学
生物
生物化学
多糖
医学
病理
替代医学
作者
Peipei Wang,Lei Zhang,Jian Yao,Yikang Shi,Ping Li,Kan Ding
标识
DOI:10.1016/j.carbpol.2014.11.073
摘要
Angiogenesis plays an essential role in tumor development. Blocking angiogenesis in tumor has become a promising tactic in limiting cancer progression. Here, an arabinogalactan polysaccharide, RN1 was isolated from flowers of Panax notoginseng. Its structure was determined to possess a backbone of 1,6-linked Galp branched at C3 by side 1,3-linked Galp, with branches attached at position O-3 of it. The branches mainly contained 1,5-linked, 1,3,5-linked, terminal Arabinose and terminal Galactose. RN1 could inhibit microvessel formation in the BxPC-3 pancreatic cancer cell xenograft tumor in nude mice. The antiangiogenesis assay showed that RN1 could reduce the migratory activity of endothelial cells and their ability of tube formation on matrigel, but no effect on endothelial cells growth. Further studies revealed that RN1 could inhibit BMP2/Smad1/5/8/Id1 signaling. All those data indicated the RN1 had an antiangiogenic effect via BMP2 signaling and could be a potential novel inhibitor of angiogenesis.
科研通智能强力驱动
Strongly Powered by AbleSci AI